International Metals Min...【IMM】銘柄情報

International Metals Mining Corp (IMM) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.085

( -22.73% )

買値

0.09

売値

0.115

出来高

18,503

0.085 日の範囲 0.11

0.06 52 週間の範囲 0.16

時価総額

1.912M

前日終値

0.11

始値

0.11

時刻

0.11

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 50,959

発行済株式数

22,491,713

配当利回り

PER

-1.54

1 株当たり利益 (EPS)

-0.07

歳入

純利益

-879.91k

International Metals Mining Corp. acquires, explores for, and develops mineral properties in North America. It explores for gold and copper deposits. The company was formerly known as Gold State Resources Inc. and changed its name to International Metals Mining Corp. in October 2022. International M... International Metals Mining Corp. acquires, explores for, and develops mineral properties in North America. It explores for gold and copper deposits. The company was formerly known as Gold State Resources Inc. and changed its name to International Metals Mining Corp. in October 2022. International Metals Mining Corp. is headquartered in Vancouver, Canada. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

internationalmetalscorp.com

本社

Vancouver, Canada

設立

International Metals Mining Corp is listed in the Materials sector of the トロントベンチャー取引所 with ticker IMM. The last closing price for International Metals Min... was $0.11. Over the last year, International Metals Min... shares have traded in a share price range of $ 0.06 to $ 0.16.

International Metals Min... currently has 22,491,713 shares in issue. The market capitalisation of International Metals Min... is $1.91 million. International Metals Min... has a price to earnings ratio (PE ratio) of -1.54.

Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal®

Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal® PR Newswire MONTREAL, July 26, 2011 MONTREAL...

Important New Research using Immunocal® Shows Promise in Lou Gehrig's Disease

Important New Research using Immunocal® Shows Promise in Lou Gehrig's Disease PR Newswire MONTREAL, June 14, 2011 MONTREAL, June 14, 2011...

Immtech to be Listed on OTC Market

NEW YORK, May 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (OTC:IMMP) announced today that the Company expects to begin trading...

Immtech to Reorganize Research and Development Operations

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that the Company is reorganizing its...

Immtech Announces Investment in China

NEW YORK, April 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that it has made an investment in...

Immtech Receives Listing Determination Letter

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE AMEX: IMM) today announced that on March 27, 2009, the Company...

Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.025	-22.7272727273	0.11	0.15	0.08	65125	0.08216507	CS
4	-0.025	-22.7272727273	0.11	0.15	0.08	17408	0.08259645	CS
12	-0.035	-29.1666666667	0.12	0.16	0.06	7038	0.08904932	CS
26	-0.02	-19.0476190476	0.105	0.16	0.06	5745	0.09743773	CS
52	0.025	41.6666666667	0.06	0.16	0.06	13523	0.09625976	CS
156	-0.175	-67.3076923077	0.26	0.355	0.02	19487	0.12802229	CS
260	-0.015	-15	0.1	0.355	0.02	18294	0.13043153	CS